Textbook of Interventional Cardiology

Eric Topol is one of the most influential cardiologists and scientists in the world, a true "rock star” in cardiology. He is internationally known due to his serving as Editor-in-Chief of Medscape, his numerous multi-million dollar ground-breaking NIH research studies, his widely adopted medical innovations, and his frequent appearances on broadcast television. He is the founding director of the Scripps Translational Institute where large multidisciplinary teams investigate medical innovations in practice, research, and education for the future of medicine. Because of Dr Topol's incredibly busy schedule and the fact that Dr Teirstein acted as lead editor on the current edition, Dr Topol has proposed a succession plan for the revision, with his colleague Dr Teirstein officially lead editor and the addition of their colleague Dr Price as a second new editor, and a title change from Textbook of Interventional Cardiology to Topol's Textbook of Interventional Cardiology. Paul Teirstein, MD, is Chief of Cardiology, Director of Interventional Cardiology, and Medical Director at the Scripps Prebys Cardiovascular Institute/Scripps Clinic in La Jolla, California.

• 1. Individualized Assessment for Percutaneous or. Surgical-Based Revascularization2. Evidence-Based Interventional Practice3. Diabetes4. Noninvasive Evaluation: Functional Testing,Multidetector Computed Tomography, and Stress. Cardiac MRI5. Intracoronary Pressure and Flow Measurements6. Contrast-Induced Acute Kidney Injury and the Role of Chronic Kidney Disease in Percutaneous Coronary Intervention7. Radiation Safety During Cardiovascular. Procedures8. Coronary and Valvular Intervention Prior to. Noncardiac Surgery9. Sex and Ethnicity Issues in Interventional. Cardiology10. Platelet Inhibitor Agents11. Anticoagulation in Percutaneous Coronary. Intervention12. Thrombolytic Intervention13. Other Adjunctive Drugs for Coronary. Intervention: Beta-Blockers, Calcium-Channel Blockers, and Angiotensin-Converting Enzyme Inhibitors14. Coronary Stenting: Practical Considerations,. Equipment Selection, Tips and Caveats15. Coronary Stenting16. Bioresorbable Coronary Scaffolds17. Drug-Eluting Balloons18. Elective Intervention for Stable Angina or Silent Ischemia19. Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes20. Percutaneous Coronary Intervention in Acute. ST-Segment Elevation Myocardial Infarction21. Post-Percutaneous Coronary Intervention Hospitalization, Length of Stay, and Discharge. Planning22. Interventions in Cardiogenic Shock23. Bifurcations and Branch Vessel Stenting24. Percutaneous Coronary Intervention for. Unprotected Left Main Coronary Artery Stenosis25. Complex and Multivessel Percutaneous Coronary Intervention26. Intervention for Coronary Chronic Total. Occlusions27. Bypass Graft Intervention28. The Thrombus-Containing Lesion29. Complications of Percutaneous Coronary. Intervention30. Periprocedural Myocardial Infarction and. Embolism-Protection Devices31. Access Management and Closure Devices32. Transradial Access for Cardiovascular. Catheterization and Intervention33. Role of the Cardiac Surgeon and the Heart Team34. Restenosis35. Role of Adjunct Devices: Atherectomy, Cutting Balloon, and Laser36. Supported Percutaneous Intervention37. Regional Centers of Excellence for the Care of Patients With Acute Ischemic Heart Disease38. Diagnosis and Treatment of Coronary. Microvascular Disease39. Lower Extremity Interventions40. Upper Extremities and Aortic Arch41. Chronic Mesenteric Ischemia: Diagnosis and. Intervention42. Renal Artery Stenosis43. Device Therapy for Resistant Hypertension44. Aortic Vascular Interventions (Thoracic and. Abdominal)45. Venous Intervention46. Carotid and Cerebrovascular Intervention47. Stroke Centers and Interventional Cardiology48. Imaging for Intracardiac Interventions49. Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect50. Left Atrial Appendage Closure and Stroke:. Local Device Therapy for Cardioembolic Stroke. Protection51. Mitral Valvuloplasty52. Percutaneous Mitral Valve Repair and. Replacement53. Balloon-Expandable Transcatheter Aortic Valve. Replacement Systems54. Self-Expanding Transcatheter Aortic Valve. Replacement55. Percutaneous Transcatheter Valve-in-Valve. Implantation56. Pulmonary Valve Interventions57. Percutaneous Tricuspid Valve Repair58. Hypertrophic Cardiomyopathy59. Percutaneous Balloon Pericardiotomy for Patients With Pericardial Effusion and Tamponade60. Transcatheter Therapies for Congenital Heart. Disease61. Stem Cell Therapy for Ischemic Heart Disease62. Percutaneous Treatment of Paravalvular Leak63. Interventional Heart Failure64. Qualitative and Quantitative Coronary. Angiography65. Intravascular Ultrasound66. The Dynamic Spectrum of Coronary Atheroma: From Atherogenesis to Vulnerable Plaque to Plaque Regression67. Optical Coherence Tomography68. Medical Economics in Interventional. Cardiology69. Quality of Care in Interventional Cardiology70. Volume and Outcome